Home > Offer to Sell > Pharmaceuticals and Biochemicals > Hormones and synthetic substitutes > The Second Generation of Aromatase Inhibitors and Have Good Effect; CAS: 107868-30-4
The Second Generation of Aromatase Inhibitors and Have Good Effect; CAS: 107868-30-4
Inquiry
| Post Date: | Dec 20,2017 |
| Expiry Date: | Dec 20,2018 |
| Detailed Description: |
Cas No. :107868-30-4
Quantity: 1Kilograms Specs:USP/BP/EP/CP Price:1 USD Kilograms Payment Method: T/T Synonyms:6-methylenandrosta-1,4-diene-3,17-dione;androsta-1,4-diene-6-methylene-3,17-dione;6-METHYLENEANDROSTA-1,4-DIENE-3,17-DIONE;6-Methylene-androsta-1,4-diene-3,17-dione;AROMASIN;EXALAMIDE;6-methylenandrost-1,4-diene-3,17-dione;6-Methyleneandrosta-1,4-diene-3,17-dione; CAS 107868-30-4 MF C20H24O2 MW 296.40300 Quality 296.17800 PSA 34.14000 LogP 4.02950 Physical and chemical properties Appearance and properties white to pale yellow crystalline powder density 1.13 g/cm3 melting point 155.13 ° C boiling point 453.7DHS C at 760 mmHg flash point 169 DHS C refractive index 1.572 storage conditions Store in the original container in a cool dark place steam pressure 2.02 e-08 mmHg at 25 ° C Introduction of compounds (trade name Aromasin) is a drug used to treat breast cancer. It is a member of the class of drugs known as aromatase inhibitors. Some breast cancers require estrogen to grow. Those cancers have estrogen receptors (ERs), and are called ER-positive. They may also be called estrogen-responsive, hormonally-responsive, or hormone-receptor-positive. Aromatase is an enzyme that synthesizes estrogen. Aromatase inhibitors block the synthesis of estrogen. This lowers the estrogen level, and slows the growth of cancers. use is the second generation aromatase inhibitors, its role is different from the anti-estrogen drugs, it can combine with aromatase and irreversible inactivated, thus reduce circulating estrogen levels rapidly and consistently, inhibits tumor growth. The role of the drug than the same kind of aromatase inhibitors f beauty is better, and less toxicity. More importantly, this product does not exist the former oral coupling faults occur, can be made into a variety of dosage forms. Clinically for the treatment of metastatic breast cancer and used as adjuvant therapy of early breast cancer, curative effect and good tolerance, relatively few side effects. |
| CAS Registry Number: | 107868-30-4 |
| Synonyms: | ;Exemestan;6-Methylenandrosta-1,4-diene-3,17-dione;10,13-Dimethyl-6-methylidene-7,8,9,10,11,12,13,14,15,16-decahydrocyclopenta[a]phenanthrene-;6-methylideneandrosta-1,4-diene-3,17-dione;(8ξ,9ξ,14ξ)-6-methylideneandrosta-1,4-diene-3,17-dione;Exemestane(Aromasin);Exemestone; |
| Molecular Formula: | C20H24O2 |
| Molecular Weight: | 296.4034 |
| Molecular Structure: | 
|
| Company: | WUHAN DONG KANG YUAN TECHNOLOGY CO., LTD. [ China ] |
| Contact: | zhang |
| Tel: | 86-027-81302267 |
| Fax: | 86-027-81302088 |
| Email: | zh@dkybpc.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
